What is CPC Pathology?
CPC Pathology provides a comprehensive suite of pathology services, encompassing both anatomic and clinical pathology. The company is distinguished by its team of board-certified and subspecialty-certified pathologists, each possessing over two decades of experience. CPC Pathology operates under stringent quality standards, holding accreditations from the College of American Pathologists and Clinical Laboratory Improvement Amendments, which attest to its commitment to high-quality diagnostics. The firm emphasizes personalized client service, rapid turnaround times for results, and maintains a reliable courier network to efficiently serve healthcare providers seeking dependable pathology support and diagnostic solutions.
How much funding has CPC Pathology raised?
CPC Pathology has raised a total of $644K across 1 funding round:
Debt
$644K
Debt (2021): $644K with participation from PPP
Key Investors in CPC Pathology
PPP
Public-Private Partnership
What's next for CPC Pathology?
The recent major strategic investment signals a pivotal moment for CPC Pathology, likely enabling the company to scale its operations, enhance its diagnostic capabilities, and potentially expand its service offerings. This influx of capital, categorized as enterprise-level funding, suggests a focus on significant growth initiatives, such as technological advancements in laboratory services, broader market penetration, or strategic partnerships within the healthcare ecosystem. The company is well-positioned to leverage this financial backing to solidify its market standing and pursue ambitious expansion plans.
See full CPC Pathology company page
